US Stock MarketDetailed Quotes

CLGN Collplant

Watchlist
  • 5.970
  • +0.080+1.36%
Close Apr 29 16:00 ET
68.38MMarket Cap-9629P/E (TTM)

About Collplant Company

CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. It engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. Its products include VergenixSTR, VergenixFG, and Collink.3D. The company was founded by Oded Shoseyov in June 2004 and is headquartered in Rehovot, Israel.

Company Profile

SymbolCLGN
Company NameCollplant
Listing DateJan 31, 2018
Founded2004
CEOMr. Yehiel Tal
MarketNASDAQ
Employees75
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressWeizmann Science Park,4 Oppenheimer Street
CityRehovot
ProvinceTel Aviv
CountryIsrael
Zip Code7670104
Phone972-73-232-5600
Websitehttp://www.collplant.com

Company Executives

  • Name
  • Position
  • Salary
  • Yehiel Tal
  • Chief Executive Officer and Director
  • 1.08M
  • Eran Rotem
  • Deputy Chief Executive Officer and Chief Financial Officer
  • 748.00K
  • Hadas Dreiher Horowitz
  • Vice President, Human Resources
  • --
  • Oren Fahimipoor
  • Vice President, Operations
  • 323.00K
  • Dr. Philippe Bensimon
  • Vice President, Regulatory Affairs and Quality Assurance
  • 362.00K
  • Dr. Elana Gazal, PhD
  • Vice President, Research and Development
  • 379.00K
  • Dr. Roger J. Pomerantz, F.A.C.P.,M.D.
  • Chairman of the Board
  • --
  • Joseph Zarzewsky
  • Independent Director
  • --
  • Dr. Abraham Havron, PhD
  • Independent Director
  • --
  • Alisa Lask
  • Independent Director
  • --
  • Hugh Evans
  • Independent Director
  • --
  • Dr. Elan Penn,PhD
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg